Autonomix Medical Inc (AMIX)

$1.51 +0.06 (4.14%)
Market Cap 3.95M
Revenue (ttm) 0.00
Net Income (ttm) -11.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 115,600
Avg Vol 1,193,404
Day's Range N/A - N/A
Shares Out 2.78M
Stochastic %K 18%
Beta -2.99
Analysts Strong Sell
Price Target $11.50

Company Profile

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related diso...

Industry: Medical Devices
Sector: Healthcare
Phone: 713 588 6150
Address:
21 Waterway Avenue, Suite 300, The Woodlands, United States
fromtheothersid3
fromtheothersid3 Jul. 9 at 6:29 PM
$AMIX imho this one could turn out to be the next $MBIO Kets see ☺️
1 · Reply
fromtheothersid3
fromtheothersid3 Jul. 9 at 5:59 PM
$AMIX really like this
0 · Reply
Righon23420
Righon23420 Jul. 9 at 5:55 AM
$AMIX LFG!
0 · Reply
coolmate25
coolmate25 Jul. 8 at 4:15 PM
$AMIX
0 · Reply
coolmate25
coolmate25 Jul. 7 at 8:10 PM
$AMIX Same old shit , seems like a couple of MFS are messing with it lol .
0 · Reply
fromtheothersid3
fromtheothersid3 Jul. 7 at 3:02 PM
$AMIX is my personal Favorite to be the next $MBIO imho Lets see ☺️
0 · Reply
coolmate25
coolmate25 Jul. 7 at 2:03 PM
$AMIX Come on guys ! Why is everyone dead ! Wake up , buy and hold .
2 · Reply
WrappedLunatic
WrappedLunatic Jul. 7 at 11:14 AM
$AMIX ouch ouch
0 · Reply
WrappedLunatic
WrappedLunatic Jul. 7 at 11:14 AM
$AMIX ouch
0 · Reply
coolmate25
coolmate25 Jul. 3 at 7:59 PM
$AMIX Most of the stock market was up today but Amix , just because of low life shorts and dumpers dealing with it .
0 · Reply
Latest News on AMIX
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Jul 7, 2025, 8:30 AM EDT - 2 days ago

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Jun 30, 2025, 8:30 AM EDT - 9 days ago

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Jun 27, 2025, 8:00 AM EDT - 12 days ago

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Jun 5, 2025, 8:45 AM EDT - 4 weeks ago

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

May 15, 2025, 8:30 AM EDT - 7 weeks ago

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

May 14, 2025, 9:20 AM EDT - 2 months ago

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

May 13, 2025, 9:20 AM EDT - 2 months ago

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

May 5, 2025, 8:30 AM EDT - 2 months ago

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

May 1, 2025, 9:25 AM EDT - 2 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Apr 30, 2025, 8:15 AM EDT - 2 months ago

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Apr 24, 2025, 8:30 AM EDT - 2 months ago

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 17, 2025, 5:00 PM EDT - 2 months ago

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Apr 16, 2025, 8:30 AM EDT - 3 months ago

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Apr 8, 2025, 8:15 AM EDT - 3 months ago

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Apr 3, 2025, 8:30 AM EDT - 3 months ago

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Mar 20, 2025, 8:30 AM EDT - 3 months ago

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Mar 14, 2025, 8:30 AM EDT - 4 months ago

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Feb 20, 2025, 8:30 AM EST - 4 months ago

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Feb 13, 2025, 8:00 AM EST - 5 months ago

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Jan 24, 2025, 8:45 AM EST - 5 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Jan 17, 2025, 8:00 AM EST - 6 months ago

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Jan 15, 2025, 8:30 AM EST - 6 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Jan 13, 2025, 8:30 AM EST - 6 months ago

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Dec 30, 2024, 8:30 AM EST - 6 months ago

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Dec 5, 2024, 8:30 AM EST - 7 months ago

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Nov 25, 2024, 4:00 PM EST - 8 months ago

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

Nov 22, 2024, 9:15 AM EST - 8 months ago

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Nov 11, 2024, 8:00 AM EST - 8 months ago

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Oct 30, 2024, 8:30 AM EDT - 9 months ago

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Oct 28, 2024, 12:06 PM EDT - 9 months ago

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?

Oct 28, 2024, 11:08 AM EDT - 9 months ago

Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?

Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th

Oct 25, 2024, 11:30 AM EDT - 9 months ago

Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th

Autonomix Announces Reverse Stock Split

Oct 22, 2024, 8:30 AM EDT - 9 months ago

Autonomix Announces Reverse Stock Split

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

Oct 8, 2024, 8:30 AM EDT - 9 months ago

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum

Sep 20, 2024, 8:30 AM EDT - 10 months ago

Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 8:30 AM EDT - 11 months ago

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

Aug 21, 2024, 8:30 AM EDT - 11 months ago

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones

Aug 13, 2024, 8:00 AM EDT - 11 months ago

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License Agreement

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License Agreement

Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment

Jul 3, 2024, 9:00 AM EDT - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment

Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer

Jun 17, 2024, 4:05 PM EDT - 1 year ago

Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial

Jun 3, 2024, 8:15 AM EDT - 1 year ago

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial

Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update

May 31, 2024, 8:05 AM EDT - 1 year ago

Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update

Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

May 23, 2024, 9:15 AM EDT - 1 year ago

Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Apr 24, 2024, 9:00 AM EDT - 1 year ago

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain

Apr 16, 2024, 9:00 AM EDT - 1 year ago

Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain

Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation

Apr 9, 2024, 8:30 AM EDT - 1 year ago

Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation

Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker

Apr 8, 2024, 8:30 AM EDT - 1 year ago

Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker

Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

Mar 27, 2024, 9:00 AM EDT - 1 year ago

Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024

Mar 20, 2024, 8:05 AM EDT - 1 year ago

Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024

fromtheothersid3
fromtheothersid3 Jul. 9 at 6:29 PM
$AMIX imho this one could turn out to be the next $MBIO Kets see ☺️
1 · Reply
fromtheothersid3
fromtheothersid3 Jul. 9 at 5:59 PM
$AMIX really like this
0 · Reply
Righon23420
Righon23420 Jul. 9 at 5:55 AM
$AMIX LFG!
0 · Reply
coolmate25
coolmate25 Jul. 8 at 4:15 PM
$AMIX
0 · Reply
coolmate25
coolmate25 Jul. 7 at 8:10 PM
$AMIX Same old shit , seems like a couple of MFS are messing with it lol .
0 · Reply
fromtheothersid3
fromtheothersid3 Jul. 7 at 3:02 PM
$AMIX is my personal Favorite to be the next $MBIO imho Lets see ☺️
0 · Reply
coolmate25
coolmate25 Jul. 7 at 2:03 PM
$AMIX Come on guys ! Why is everyone dead ! Wake up , buy and hold .
2 · Reply
WrappedLunatic
WrappedLunatic Jul. 7 at 11:14 AM
$AMIX ouch ouch
0 · Reply
WrappedLunatic
WrappedLunatic Jul. 7 at 11:14 AM
$AMIX ouch
0 · Reply
coolmate25
coolmate25 Jul. 3 at 7:59 PM
$AMIX Most of the stock market was up today but Amix , just because of low life shorts and dumpers dealing with it .
0 · Reply
coolmate25
coolmate25 Jul. 3 at 5:02 PM
$AMIX Here we go again , same old sh-t again . Day traders fcked up again on short day , trying getting $2 a day to eat big mc deal for their poor hungry ars lol
0 · Reply
Righon23420
Righon23420 Jul. 3 at 4:05 AM
$AMIX this is still a bargain! Expanded application clinical trial just started with first patient already treated. High probablilty of very positive results! Will immediately double the target market. This is just the beginning as there is not doubt many more applications for their patented treatment.
0 · Reply
coolmate25
coolmate25 Jul. 2 at 7:36 PM
$AMIX I wish some low life MFS let it breath but always end up in sell offs . Just a big FU to them and for the rest May God bless them.
0 · Reply
mikailoral
mikailoral Jul. 2 at 4:54 PM
$AMIX 🚀
0 · Reply
coolmate25
coolmate25 Jul. 1 at 8:02 PM
$AMIX Can't believe all that day traders low life Mfs sold it at the end of the day . Wish we find some long term professionals to hold it for at least a week .
1 · Reply
fromtheothersid3
fromtheothersid3 Jul. 1 at 6:21 PM
$AMIX setting up again... Back in 1,51 Lets go squeezeee em
1 · Reply
Ml8216
Ml8216 Jul. 1 at 10:28 AM
$AMIX will we turn theese red days you think?
0 · Reply
ATLDawg
ATLDawg Jul. 1 at 12:55 AM
$AMIX $BMNR $CTOR $HYPD $IPDN
1 · Reply
fromtheothersid3
fromtheothersid3 Jun. 30 at 11:29 PM
$AMIX 2,30 plus tomorrow ☺️
0 · Reply
coolmate25
coolmate25 Jun. 30 at 8:14 PM
$AMIX sell offs continues by some low life poor souls getting $2 a day income .
0 · Reply
coolmate25
coolmate25 Jun. 30 at 8:02 PM
$AMIX All day pretty much flat today since some imature unprofessional investors were confused lol.
0 · Reply
Hazel1401
Hazel1401 Jun. 30 at 7:35 PM
$AMIX 10,000 here at 1.58/59 gl
0 · Reply